Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 8;9(7):390.
doi: 10.3390/antibiotics9070390.

Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from Sphaeranthus africanus Against Mycobacteria

Affiliations

Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from Sphaeranthus africanus Against Mycobacteria

Huyen Thi Tran et al. Antibiotics (Basel). .

Abstract

Carvotacetones (1-7) isolated from Sphaeranthus africanus were screened for their antimycobacterial and efflux pump (EP) inhibitory potential against the mycobacterial model strains Mycobacterium smegmatis mc2 155, Mycobacterium aurum ATCC 23366, and Mycobacterium bovis BCG ATCC 35734. The minimum inhibitory concentrations (MICs) of the carvotacetones were detected through high-throughput spot culture growth inhibition (HT-SPOTi) and microbroth dilution assays. In order to assess the potential of the compounds 1 and 6 to accumulate ethidium bromide (EtBr) in M. smegmatis and M. aurum, a microtiter plate-based fluorometric assay was used to determine efflux activity. Compounds 1 and 6 were analyzed for their modulating effects on the MIC of EtBr and the antibiotic rifampicin (RIF) against M. smegmatis. Carvotacetones 1 and 6 had potent antibacterial effects on M. aurum and M. bovis BCG (MIC ≤ 31.25 mg/L) and could successfully enhance EtBr activity against M. smegmatis. Compound 1 appeared as the most efficient agent for impairing the efflux mechanism in M. smegmatis. Both compounds 1 and 6 were highly effective against M. aurum and M. bovis BCG. In particular, compound 1 was identified as a valuable candidate for inhibiting mycobacterial efflux mechanisms and as a promising adjuvant in the therapy of tuberculosis or other non-tubercular mycobacterial infections.

Keywords: Compositae; Sphaeranthus africanus L.; carvotacetones; efflux pump inhibitors; efflux pumps; ethidium bromide accumulation; mycobacteria.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Chemical structures of compounds 1–7 isolated from Sphaeranthus africanus [21,22].
Figure 2
Figure 2
The increase of EtBr accumulation in M. smegmatis mc2 155 (a) and M. aurum ATCC 23366 (b) generated by concentrations MIC/2 of the potential efflux pump inhibitors (EPIs) 1 and 6 and the reference inhibitors, verapamil (VP) and chlorpromazine (CPZ), included as two positive controls. EtBr, the negative control, was tested at 0.5 mg/L. The curves represent means ± standard deviations (SD); n = 3.

Similar articles

Cited by

References

    1. Baker S.J., Payne D.J., Rappuoli R., De Gregorio E. Technologies to address antimicrobial resistance. Proc. Natl. Acad. Sci. USA. 2018;115:12887–12895. doi: 10.1073/pnas.1717160115. - DOI - PMC - PubMed
    1. Aslam B., Wang W., Arshad M.I., Khurshid M., Muzammil S., Rasool M.H., Nisar M.A., Alvi R.F., Aslam M.A., Qamar M.U. Antibiotic resistance: A rundown of a global crisis. Infect. Drug Resist. 2018;11:1645. doi: 10.2147/IDR.S173867. - DOI - PMC - PubMed
    1. Tacconelli E., Carrara E., Savoldi A., Harbarth S., Mendelson M., Monnet D.L., Pulcini C., Kahlmeter G., Kluytmans J., Carmeli Y. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 2018;18:318–327. doi: 10.1016/S1473-3099(17)30753-3. - DOI - PubMed
    1. Solnier J., Martin L., Bhakta S., Bucar F. Flavonoids as novel efflux pump inhibitors and antimicrobials against both environmental and pathogenic intracellular mycobacterial species. Molecules. 2020;25:734. doi: 10.3390/molecules25030734. - DOI - PMC - PubMed
    1. Fair R.J., Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect. Med. Chem. 2014;6:PMC.S14459. doi: 10.4137/PMC.S14459. - DOI - PMC - PubMed

LinkOut - more resources

-